Jianwei Yang
Fujian Cancer Hospital
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yimin Mao
RenJi Hospital
Shared therapeutic areas:
Worked with same sponsors:
Peng Hu
The Second Affiliated Hospital of Chongqing Medical University
Shared therapeutic areas:
Worked with same sponsors:
Xiaoyan Wang
The Third Xiangya Hospital of Central South University
Shared therapeutic areas:
Worked with same sponsors:
Liaoyun Zhang
The First Affiliated Hospital of Shanxi Medical University
Shared therapeutic areas:
Worked with same sponsors:
Chengwei Chen
No.85 hospital of PLA
Shared therapeutic areas:
Worked with same sponsors:
Yan Huang
Xiangya Hospital of Central South University
Shared therapeutic areas:
Worked with same sponsors:
Yongguo Li
First Affiliated Hospital of Harbin Medical University
Shared therapeutic areas:
Worked with same sponsors:
Qing Ye
Tianjin Third Central Hospital
Shared therapeutic areas:
Guizhou Zou
The Second Hospital of Anhui Medical University
Shared therapeutic areas:
Worked with same sponsors:
Yuemin Nan
Hebei Medical University Third Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）
Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA
mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA
All 3 trials loaded